Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Learn which bonds in a ladder contribute most to tax efficiency and why. This primer covers selection criteria to help you reduce tax drag in retirement income planning.
22,177 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Long-term Treasuries moved higher again, signaling tougher borrowing costs ahead. The bond market just handed U.S. ta...
NVIDIA guided higher-than-expected revenue for the coming quarter, but investors greeted the news with a muted respon...
Berkshire Hathaway reports a record cash and Treasury position, signaling Buffett’s readiness to act when markets dis...
Take-Two is set to report Q4 results after market close, with GTA VI's looming launch shaping investor sentiment. Gui...
Investors are watching Redwire as its stock keeps rising, driven by backlog gains and contract momentum. This guide b...
A year-long selloff in monday.com highlights how a single large exit can ripple through stock prices, risk, and inves...
NVIDIA has redefined its role in the AI era, but the upside isn’t finished. This piece unpack three practical reasons...
Bitcoin trades in a narrow range as investors digest looming macro data and a cooling appetite for risk. Analysts war...
Intuitive Machines has captured investor attention as space missions gain traction. This guide breaks down the main d...
When Cerebras surged 68% on its first trading day, investors sat up and took notice. This piece breaks down what that...
Investors are watching GameSquare closely as 2025 earnings unfold. This guide explains what to look for in the Q4 res...